SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 68,352 shares were traded during trading, a decline of 7% from the previous session's volume of 73,865 shares.The stock last traded at $5.44 and had previously closed at $5.65.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised shares of SBC Medical Group to a "strong-buy" rating in a research note on Saturday, June 21st.
Check Out Our Latest Research Report on SBC Medical Group
SBC Medical Group Price Performance
The company has a debt-to-equity ratio of 0.03, a current ratio of 4.44 and a quick ratio of 4.40. The business's 50 day moving average is $4.61 and its 200 day moving average is $4.32.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last issued its earnings results on Thursday, May 15th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.11 by $0.10. The business had revenue of $47.33 million during the quarter, compared to analyst estimates of $51.52 million. Equities analysts forecast that SBC Medical Group Holdings Incorporated will post 5.02 EPS for the current year.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Featured Stories
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access